A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
New Treatment Option for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Maintenance Gemcitabine in the Chinese Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and CT-011 for Resected Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
- Status
- COMPLETED
- Phase
- PHASE1